Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Clinical trials from the patient perspective: survey in an online patient community.

DasMahapatra P, Raja P, Gilbert J, Wicks P.

BMC Health Serv Res. 2017 Feb 27;17(1):166. doi: 10.1186/s12913-017-2090-x.

2.

African-American patients with cancer Talking About Clinical Trials (TACT) with oncologists during consultations: evaluating the efficacy of tailored health messages in a randomised controlled trial-the TACT study protocol.

Brown RF, Davis R, Wilson Genderson M, Grant S, Cadet D, Lessard M, Alpert J, Ward J, Ginder G.

BMJ Open. 2016 Dec 16;6(12):e012864. doi: 10.1136/bmjopen-2016-012864.

3.

Factors influencing willingness to participate in new drug trial studies: a study among parents whose children were recruited into these trials in northern Ghana.

Akazili J, Chatio S, Achana FS, Oduro A, Kanmiki EW, Baiden F.

BMC Res Notes. 2016 Mar 3;9:139. doi: 10.1186/s13104-016-1951-4.

4.

Factors associated with (non-)participation of cancer survivors with job loss in a supportive return to work program.

van Egmond MP, Anema JR, Singh A, van der Beek AJ, Duijts SF.

Support Care Cancer. 2016 Jul;24(7):3175-84. doi: 10.1007/s00520-016-3130-5. Epub 2016 Mar 2.

5.

Understanding involvement in surgical orthopaedic randomized controlled trials: A qualitative study of patient and health professional views and experiences.

Horwood J, Johnson E, Gooberman-Hill R.

Int J Orthop Trauma Nurs. 2016 Feb;20:3-12. doi: 10.1016/j.ijotn.2015.05.002. Epub 2015 May 14.

6.

A European multi-language initiative to make the general population aware of independent clinical research: the European Communication on Research Awareness Need project.

Mosconi P, Antes G, Barbareschi G, Burls A, Demotes-Mainard J, Chalmers I, Colombo C, Garattini S, Gluud C, Gyte G, Mcllwain C, Penfold M, Post N, Satolli R, Valetto MR, West B, Wolff S.

Trials. 2016 Jan 12;17:19. doi: 10.1186/s13063-015-1146-7.

7.

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases.

Lux MP, Hildebrandt T, Knetzger SM, Schrauder MG, Jud SM, Hein A, Rauh C, Fasching PA, Beckmann MW, Thiel FC.

BMC Cancer. 2015 Aug 14;15:587. doi: 10.1186/s12885-015-1584-3.

8.

Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.

Gerber DE, Lakoduk AM, Priddy LL, Yan J, Xie XJ.

Oncologist. 2015 Jun;20(6):674-82. doi: 10.1634/theoncologist.2015-0083. Epub 2015 May 27.

9.

Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationale.

Blake K, Holbrook JT, Antal H, Shade D, Bunnell HT, McCahan SM, Wise RA, Pennington C, Garfinkel P, Wysocki T.

Contemp Clin Trials. 2015 May;42:105-18. doi: 10.1016/j.cct.2015.03.012. Epub 2015 Apr 3.

10.

Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancer.

Behrendt CE, Hurria A, Tumyan L, Niland JC, Mortimer JE.

J Natl Compr Canc Netw. 2014 Nov;12(11):1579-85.

11.

Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives.

Chalela P, Suarez L, Muñoz E, Gallion KJ, Pollock BH, Weitman SD, Karnad A, Ramirez AG.

J Community Med Health Educ. 2014 Apr 24;4(281):1000281.

12.

Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation.

Keusch F, Rao R, Chang L, Lepkowski J, Reddy P, Choi SW.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1604-11. doi: 10.1016/j.bbmt.2014.06.020. Epub 2014 Jun 24.

13.

Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study.

Fleisher L, Ruggieri DG, Miller SM, Manne S, Albrecht T, Buzaglo J, Collins MA, Katz M, Kinzy TG, Liu T, Manning C, Charap ES, Millard J, Miller DM, Poole D, Raivitch S, Roach N, Ross EA, Meropol NJ.

Patient Educ Couns. 2014 Jul;96(1):63-71. doi: 10.1016/j.pec.2014.04.009. Epub 2014 Apr 21.

14.

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

Manne S, Kashy D, Albrecht T, Wong YN, Lederman Flamm A, Benson AB 3rd, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJ.

Eur J Cancer Care (Engl). 2015;24(1):28-38. doi: 10.1111/ecc.12180. Epub 2014 Jan 28.

15.

Rehabilitation research: who is participating?

Patterson KK.

Physiother Can. 2013 Summer;65(3):201-3. doi: 10.3138/ptc.65.3.GEE. English, French. No abstract available.

16.

Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study.

Mao JJ, Tan T, Li SQ, Meghani SH, Glanz K, Bruner D.

BMC Complement Altern Med. 2014 Jan 8;14:7. doi: 10.1186/1472-6882-14-7.

17.

Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say?

Brown RF, Cadet DL, Houlihan RH, Thomson MD, Pratt EC, Sullivan A, Siminoff LA.

J Oncol Pract. 2013 Nov;9(6):287-93. doi: 10.1200/JOP.2013.001039. Epub 2013 Oct 15.

18.

Automated determination of metastases in unstructured radiology reports for eligibility screening in oncology clinical trials.

Petkov VI, Penberthy LT, Dahman BA, Poklepovic A, Gillam CW, McDermott JH.

Exp Biol Med (Maywood). 2013 Dec;238(12):1370-8. doi: 10.1177/1535370213508172. Epub 2013 Oct 9.

19.

Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians.

Ramirez AG, Chalela P, Suarez L, Muñoz E, Pollock BH, Weitman SD, Gallion KJ.

J Community Med Health Educ. 2012 Sep 24;2(8). pii: 1000173.

20.

Recruiting for epigenetic research: facilitating the informed consent process.

Jallo N, Lyon DE, Kinser PA, Kelly DL, Menzies V, Jackson-Cook C.

Nurs Res Pract. 2013;2013:935740. doi: 10.1155/2013/935740. Epub 2013 Jun 6.

Supplemental Content

Support Center